Cellid
Daily close in US$ at the latest USD/KRW close. Source: KRX via FinanceDataReader.
Cellid is listed on KOSDAQ and classified under Industrials, Commercial Services. Its market value is US$52.1M. In FY2025 it reported revenue of US$6.7M and an operating loss of US$8.6M.
A written company profile is not available yet; the facts above come from exchange and DART data.
Cellid in five facts
Where is Cellid listed and in which sector?
Cellid (Korean name: 셀리드) trades under KRX code 299660 on KOSDAQ, the Korea Exchange's board for smaller and growth companies. It is classified in the Industrials sector, Commercial Services.
How large is Cellid?
Its market capitalisation was US$52.1M on 2026-10-21, which puts it in this site's small-cap group. US$ amounts are converted from won at 1 USD ≈ ₩1,325 (2026-10-21).
What were Cellid's latest annual revenue and operating profit?
For fiscal year 2025, Cellid reported revenue of US$6.7M, an operating loss of US$8.6M and a net loss of US$9.1M, per its annual report on DART (data retrieved from DART on 2026-06-03). Revenue was up 112.3% on the previous year.
Where does this data come from?
Financial statements and filings come from DART, Korea's official corporate-filing system. Share prices, market capitalisation and trading status come from KRX. Company summaries are AI-generated from the filings and may contain errors; financial figures are mapped directly from DART.
Data sources and last updated
- Filings and financial statements
- DART (dart.fss.or.kr), Korea's official corporate-filing system
- Prices, market cap, trading status
- KRX (Korea Exchange), via FinanceDataReader
- Latest annual financials
- Fiscal year 2025, data retrieved from DART on 2026-06-03
- Share price and market cap
- Close of 2026-10-21
- Currency
- US$, converted from won at 1 USD ≈ ₩1,325 (2026-10-21 close)
- Company data updated
- 2026-10-21
- Company summary
- AI-generated from filings; may contain errors. Information only, not investment advice.
- [Amended] Resolution to convene a general shareholders' meeting (extraordinary meeting)Oct 21
- Proxy solicitation reference documentOct 21
- Notice of general shareholders' meetingOct 21
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- [Amended] Grant of stock optionsOct 19
- Securities issuance results (voluntary)Oct 14
- DisclosureOct 14
- [Amended] Material event report (rights offering)
Cellid updated the terms of a private placement (third-party allotment) to raise US$2.24M, about 4.5% of its market value.
Capital raise · Oct 14 - Small public offering disclosure (equity)Oct 2
- [Amended] Material event report (rights offering)
Cellid updated the terms of a private placement (third-party allotment) to raise US$2.23M, about 4.3% of its market value.
Capital raise · Oct 2 - Material event report (rights offering)
Cellid disclosed a private placement (third-party allotment) to raise US$2.22M, about 4.3% of its market value.
Capital raise · Sep 22 - [Amended] Material event report (rights offering)
Cellid updated the terms of exchangeable bonds to raise US$7.41M, about 14.4% of its market value.
Capital raise · Sep 22 - Material event report (rights offering)
Cellid disclosed a private placement (third-party allotment) to raise US$7.41M, about 14.4% of its market value.
Capital raise · Sep 22 - Agreement on change of control signed
Cellid's controlling stake is set to change hands from an individual to Huniverse Global Co., Ltd., in a deal worth US$7.28M.
Ownership change · Sep 21 - Shareholder register closure / record date setSep 21
- Resolution to convene a general shareholders' meeting (extraordinary meeting)Sep 21
- Change of 30% or more in revenue or profit/loss structure (15% for large companies)
Cellid reported separate results for FY2025: revenue of US$6.05M (+112.3% year on year), an operating loss of US$7.77M and a net loss of US$8.26M.
Earnings · Mar 5